Overview
Genetic muscular channelopathy is a group term that was previously used to describe inherited conditions affecting the ion channels in muscle cells. Ion channels are tiny protein structures in muscle cell membranes that control the flow of charged particles like sodium, potassium, chloride, and calcium. When these channels do not work properly due to genetic mutations, muscles may become overly stiff, weak, or experience episodes of paralysis. This term has been marked as obsolete in medical classification systems, meaning it is no longer used as a standalone diagnosis. Instead, the specific conditions that fall under this umbrella are now classified individually. The conditions formerly grouped under this term include myotonia congenita, paramyotonia congenita, hyperkalemic periodic paralysis, hypokalemic periodic paralysis, and other specific channelopathies. Symptoms vary depending on the exact condition but commonly include muscle stiffness (myotonia), episodes of muscle weakness or paralysis, and muscle pain. Some people experience symptoms triggered by cold temperatures, exercise, rest after exercise, or certain foods. Treatment depends on the specific type of channelopathy and may include medications such as mexiletine for myotonia, acetazolamide or dichlorphenamide for periodic paralysis, and lifestyle modifications to avoid known triggers. Genetic testing has become the standard way to identify the exact condition and guide treatment. If you have been given this diagnosis, it is important to work with your doctor to determine which specific channelopathy you have, as management strategies differ between conditions.
Key symptoms:
Muscle stiffness that improves with repeated movementEpisodes of muscle weakness or paralysisMuscle pain or crampingDifficulty relaxing muscles after gripping or contracting themWeakness triggered by cold temperaturesWeakness after resting following exerciseMuscle stiffness worsened by cold weatherDifficulty with movements after being stillFatigueSwallowing difficulties in some typesEyelid stiffness or difficulty opening eyesLegs feeling heavy or unable to move during episodes
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Genetic muscular channelopathy.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Genetic muscular channelopathy at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Genetic muscular channelopathy.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Genetic muscular channelopathy.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Genetic muscular channelopathy.
Start the conversation →Latest news about OBSOLETE: Genetic muscular channelopathy
No recent news articles for OBSOLETE: Genetic muscular channelopathy.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What specific type of muscular channelopathy do I have, and which gene is affected?,What are my specific triggers, and how can I avoid them?,Which medications are best for my type of channelopathy, and what are the side effects?,Should I have cardiac monitoring, and how often?,Is there a risk that my condition will get worse over time?,Should my family members be tested for this condition?,Are there any clinical trials or new treatments I should know about?
Common questions about OBSOLETE: Genetic muscular channelopathy
What is OBSOLETE: Genetic muscular channelopathy?
Genetic muscular channelopathy is a group term that was previously used to describe inherited conditions affecting the ion channels in muscle cells. Ion channels are tiny protein structures in muscle cell membranes that control the flow of charged particles like sodium, potassium, chloride, and calcium. When these channels do not work properly due to genetic mutations, muscles may become overly stiff, weak, or experience episodes of paralysis. This term has been marked as obsolete in medical classification systems, meaning it is no longer used as a standalone diagnosis. Instead, the specific c